Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
XBiotech
XBIT
$71M
| $500K | ﹤0.01% |
38,608
+1,856
| +5% | +$29.6K |
|
3152
Oil-Dri
ODC
$1.27B
| $496K | ﹤0.01% |
28,292
| – | – |
|
|
REV
3153
DELISTED
Revlon, Inc.
REV
| $495K | ﹤0.01% |
48,926
+5,048
| +12% | +$57K |
|
|
FTH
3154
Faeth Therapeutics
FTH
$773M
| $491K | ﹤0.01% |
2,329
-419
| -15% | -$76.3K |
|
|
MRLN
3155
DELISTED
Marlin Business Services Corp
MRLN
| $488K | ﹤0.01% |
21,948
+1,122
| +5% | +$25.2K |
|
|
ETNB
3156
DELISTED
89bio
ETNB
| $487K | ﹤0.01% |
24,809
-38,037
| -61% | -$695K |
|
3157
SAP
SAP
$242B
| $487K | ﹤0.01% |
3,605
-339
| -9% | -$49.2K |
|
3158
Mustang Bio
MBIO
$4.61M
| $482K | ﹤0.01% |
238
| – | – |
|
3159
Escalade
ESCA
$286M
| $481K | ﹤0.01% |
25,393
-96
| -0.4% | -$2.13K |
|
3160
Nathan's Famous
NATH
$399M
| $481K | ﹤0.01% |
7,861
+445
| +6% | +$29.3K |
|
|
TIG
3161
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $481K | ﹤0.01% |
46,451
-41,614
| -47% | -$494K |
|
3162
Village Super Market
VLGEA
$618M
| $479K | ﹤0.01% |
22,073
-38,361
| -63% | -$865K |
|
3163
Outlook Therapeutics
OTLK
$211M
| $478K | ﹤0.01% |
11,003
| – | – |
|
3164
Future Fuel
FF
$279M
| $477K | ﹤0.01% |
66,841
-113,069
| -63% | -$939K |
|
|
IMGO
3165
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $477K | ﹤0.01% |
+23,772
| New | +$510K |
|
|
ADVM
3166
DELISTED
Adverum Biotechnologies
ADVM
| $470K | ﹤0.01% |
21,614
-40,077
| -65% | -$1.02M |
|
3167
Western New England Bancorp
WNEB
$281M
| $470K | ﹤0.01% |
55,016
| – | – |
|
|
QTNT
3168
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $469K | ﹤0.01% |
5,005
| – | – |
|
3169
DarioHealth
DRIO
$74.8M
| $468K | ﹤0.01% |
1,712
| – | – |
|
|
CSLT
3170
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $468K | ﹤0.01% |
297,636
-408,562
| -58% | -$800K |
|
3171
Capital Bancorp
CBNK
$614M
| $463K | ﹤0.01% |
19,241
| – | – |
|
3172
Wave Life Sciences
WVE
$993M
| $459K | ﹤0.01% |
93,499
-155,302
| -62% | -$942K |
|
|
STR
3173
DELISTED
Sitio Royalties
STR
| $458K | ﹤0.01% |
24,345
-37,955
| -61% | -$708K |
|
|
ONCT
3174
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $458K | ﹤0.01% |
5,484
| – | – |
|
3175
Celcuity
CELC
$4.3B
| $456K | ﹤0.01% |
25,287
+5,882
| +30% | +$125K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.